These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38432588)

  • 1. Evaluation of infection prevention and control programmes according to the European Centre for Disease Prevention and Control and the World Health Organization in Spain 2012-2022: indicators of core component 1.
    Parra LM; Cantero M; Ortí-Lucas RM; Salcedo-Leal I; Asensio Á;
    J Hosp Infect; 2024 May; 147():17-24. PubMed ID: 38432588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of infection prevention and control in acute care hospitals in Mainland China - a systematic review.
    Wang J; Liu F; Tan JBX; Harbarth S; Pittet D; Zingg W
    Antimicrob Resist Infect Control; 2019; 8():32. PubMed ID: 30792854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)-based survey.
    Azak E; Sertcelik A; Ersoz G; Celebi G; Eser F; Batirel A; Cag Y; Ture Z; Ozturk Engin D; Yetkin MA; Kaygusuz S; Candevir A; Tartari E; Rello J; Alp E;
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):11. PubMed ID: 36782267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF).
    Aghdassi SJS; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2019; 8():73. PubMed ID: 31080588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline evaluation of the World Health Organization (WHO) infection prevention and control (IPC) core components in Pacific Island Countries and Territories (PICTs).
    Leong M; Picton R; Wratten M; Mahe A; Zimmerman PA
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):108. PubMed ID: 39334478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first WHO global survey on infection prevention and control in health-care facilities.
    Tomczyk S; Twyman A; de Kraker MEA; Coutinho Rehse AP; Tartari E; Toledo JP; Cassini A; Pittet D; Allegranzi B
    Lancet Infect Dis; 2022 Jun; 22(6):845-856. PubMed ID: 35202599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection prevention and control in Indonesian hospitals: identification of strengths, gaps, and challenges.
    Supriadi IR; Haanappel CP; Saptawati L; Widodo NH; Sitohang G; Usman Y; Anom IB; Saraswati RD; Heger M; Doevendans PA; Satari HI; Voor In 't Holt AF; Severin JA
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):6. PubMed ID: 36732802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing infection prevention and control structures in German hospitals after the COVID-19 pandemic using the WHO infection prevention and control assessment framework (IPCAF): results from 660 hospitals and comparison with a pre-pandemic survey.
    Rüther FD; Gropmann A; Hansen S; Behnke M; Geffers C; Aghdassi SJS
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):103. PubMed ID: 39272204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework.
    Aghdassi SJS; Grisold A; Wechsler-Fördös A; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):92. PubMed ID: 32571434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3).
    Zingg W; Storr J; Park BJ; Jernigan JA; Harbarth S; Grayson ML; Tacconelli E; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():74. PubMed ID: 31168366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core components of infection prevention and control programs at the facility level in Georgia: key challenges and opportunities.
    Deryabina A; Lyman M; Yee D; Gelieshvilli M; Sanodze L; Madzgarashvili L; Weiss J; Kilpatrick C; Rabkin M; Skaggs B; Kolwaite A
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):39. PubMed ID: 33627194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring healthcare-associated infections and antimicrobial use at regional level through repeated point prevalence surveys: what can be learnt?
    Arnoldo L; Smaniotto C; Celotto D; Brunelli L; Cocconi R; Tignonsini D; Faruzzo A; Brusaferro S;
    J Hosp Infect; 2019 Apr; 101(4):447-454. PubMed ID: 30597175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A self-reported survey on the implementation of infection prevention and control elements in Indian hospitals, part of a HAI surveillance network: Results from 23 hospitals conducting a standardized IPC assessment.
    Katyal S; Srivastav S; Katoch O; Rodrigues C; Rupali P; Chakrabarti A; Ray P; Biswal M; Tak V; Nath R; Mukhopadhyay C; Bhattacharya S; Padmaja K; Deotale V; Venkatesh V; Wattal C; Ma T; Nag VL; Ray R; Behera B; Baveja S; Karuna T; Singh SK; Fomda B; Devi SK; Das P; Khandelwal N; Verma P; Thangavelu P; Nazir S; Eshwara VK; Varma M; Mishra TS; Das RR; Malhotra R; Walia K; Guleria R; Mathur P
    Am J Infect Control; 2023 Jan; 51(1):29-34. PubMed ID: 35577058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the WHO core components of an infection prevention and control programme in two sub-saharan African acute health-care facilities: a mixed methods study.
    Wood R; Tembele W; Hema A; Somé A; Kinganda-Lusamaki E; Basilubo C; Lumembe R; Alama N; Mbunsu G; Zongo A; Ahuka S; Muyembe JJ; Leendertz F; Eckmanns T; Schubert G; Kagoné T; Makiala S; Tomczyk S
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):4. PubMed ID: 38221629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for healthcare-associated infection in light of two years of experience with the ECDC point prevalence survey of healthcare-associated infection and antimicrobial use in Poland.
    Deptuła A; Trejnowska E; Ozorowski T; Hryniewicz W
    J Hosp Infect; 2015 Aug; 90(4):310-5. PubMed ID: 25933918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of the infection prevention and control core components at the national level: a global situational analysis.
    Tartari E; Tomczyk S; Pires D; Zayed B; Coutinho Rehse AP; Kariyo P; Stempliuk V; Zingg W; Pittet D; Allegranzi B
    J Hosp Infect; 2021 Feb; 108():94-103. PubMed ID: 33271215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported survey on infection prevention and control structures in healthcare facilities part of a national level healthcare associated infection surveillance network in India, 2019.
    Katoch O; Katyal S; Srivastav S; Rodrigues C; Rupali P; Chakrabarti A; Ray P; Tak V; Biswal M; Nath R; Mukhopadhyay C; Bhattacharya S; Padmaja K; Deotale V; Venkatesh V; Wattal C; Ma T; Nag VL; Ray R; Behera B; Baveja S; Karuna T; Singh SK; Fomda B; Devi SK; Das P; Khandelwal N; Verma P; Gaind R; Bhattacharyya P; Kumar P; Srivastava A; Iravane J; Majumdar T; Sharma R; Sankara D; Kalwaje Eshwara V; Varma M; Nazir S; Tripathy S; Mishra S; Dey A; Thangavelu P; Kapoor L; Malhotra R; Walia K; Guleria R; Mathur P
    Am J Infect Control; 2022 Apr; 50(4):390-395. PubMed ID: 34600081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of implementation of multimodal strategies for infection prevention and control interventions and prevalence of healthcare-associated infections in Northern Italy.
    Vicentini C; Bussolino R; Gastaldo C; Castagnotto M; D'Ancona FP; Zotti CM;
    Antimicrob Resist Infect Control; 2024 Apr; 13(1):39. PubMed ID: 38605378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing of the WHO Infection Prevention and Control Assessment Framework at acute healthcare facility level.
    Tomczyk S; Aghdassi S; Storr J; Hansen S; Stewardson AJ; Bischoff P; Gastmeier P; Allegranzi B
    J Hosp Infect; 2020 May; 105(1):83-90. PubMed ID: 31870887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey.
    Loftus MJ; Curtis SJ; Naidu R; Cheng AC; Jenney AWJ; Mitchell BG; Russo PL; Rafai E; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):146. PubMed ID: 32859255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.